Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist

被引：1
|
作者：
Shenoy, Niraj [1 ]
Pagliaro, Lance [1 ]
机构：
[1] Mayo Clin, Dept Med Oncol, 200 First St SW, Rochester, MN 55905 USA
来源：
EUROPEAN UROLOGY | 2018年 / 73卷 / 02期
关键词：
HIF1-ALPHA;
D O I：
10.1016/j.eururo.2017.10.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 305
页数：4
相关论文
共 50 条
  • [31] Targeting HIF-2 as therapy for advanced cancers
    Murugesan, Thanabal
    Rajajeyabalachandran, Gurukumari
    Kumar, Swetha
    Nagaraju, Shruthi
    Jegatheesan, Sooriya Kumar
    DRUG DISCOVERY TODAY, 2018, 23 (07) : 1444 - 1451
  • [32] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
    Maeva Dufies
    Annelies Verbiest
    Lindsay S. Cooley
    Papa Diogop Ndiaye
    Xingkang He
    Nicolas Nottet
    Wilfried Souleyreau
    Anais Hagege
    Stephanie Torrino
    Julien Parola
    Sandy Giuliano
    Delphine Borchiellini
    Renaud Schiappa
    Baharia Mograbi
    Jessica Zucman-Rossi
    Karim Bensalah
    Alain Ravaud
    Patrick Auberger
    Andréas Bikfalvi
    Emmanuel Chamorey
    Nathalie Rioux-Leclercq
    Nathalie M. Mazure
    Benoit Beuselinck
    Yihai Cao
    Jean Christophe Bernhard
    Damien Ambrosetti
    Gilles Pagès
    Communications Biology, 4
  • [33] Targeting HIF2α with an RNAi therapeutic for the treatment of clear cell renal cell carcinoma
    Nicholas, A.
    Wong, S.
    Zhu, R.
    Carlson, J.
    Frankiewicz, A.
    Shu, D.
    Hamilton, H.
    Schienebeck, C.
    Andersen, A.
    Fowler-Watters, M.
    Bertin, S.
    Liu, C.
    Li, X.
    Chen, B.
    Schumacher, J.
    Hegge, J.
    Given, B.
    Li, Z.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E9 - E9
  • [34] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
    Dufies, Maeva
    Verbiest, Annelies
    Cooley, Lindsay S.
    Ndiaye, Papa Diogop
    He, Xingkang
    Nottet, Nicolas
    Souleyreau, Wilfried
    Hagege, Anais
    Torrino, Stephanie
    Parola, Julien
    Giuliano, Sandy
    Borchiellini, Delphine
    Schiappa, Renaud
    Mograbi, Baharia
    Zucman-Rossi, Jessica
    Bensalah, Karim
    Ravaud, Alain
    Auberger, Patrick
    Bikfalvi, Andreas
    Chamorey, Emmanuel
    Rioux-Leclercq, Nathalie
    Mazure, Nathalie M.
    Beuselinck, Benoit
    Cao, Yihai
    Bernhard, Jean Christophe
    Ambrosetti, Damien
    Pages, Gilles
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [35] Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
    Fan, Yang
    Li, Hongzhao
    Ma, Xin
    Gao, Yu
    Bao, Xu
    Du, Qingshan
    Ma, Minghui
    Liu, Kan
    Yao, Yuanxin
    Huang, Qingbo
    Zhang, Yu
    Zhang, Xu
    ONCOTARGET, 2016, 7 (14) : 18280 - 18294
  • [36] OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis
    Yang, Zhou
    Wei, Xiyi
    Ji, Chengjian
    Ren, Xiaohan
    Su, Wei
    Wang, Yichun
    Zhou, Jingwan
    Zhao, Zheng
    Zhou, Pengcheng
    Zhao, Kejie
    Yao, Bing
    Song, Ninghong
    Qin, Chao
    ISCIENCE, 2023, 26 (11)
  • [37] The prognosis outcome of oral squamous cell carcinoma using HIF-2α
    Lim, Elva
    Kuo, Chia-Chun
    Tu, Hsi-Feng
    Yang, Cheng-Chieh
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (10) : 651 - 656
  • [38] Author Correction: Targeting the HIF2–VEGF axis in renal cell carcinoma
    Toni K. Choueiri
    William G. Kaelin
    Nature Medicine, 2024, 30 (10) : 3027 - 3027
  • [39] Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma
    Xiong, Ying
    Liu, Li
    Xia, Yu
    Qi, Yangyang
    Chen, Yifan
    Chen, Lingli
    Zhang, Peipei
    Kong, Yunyi
    Qu, Yang
    Wang, Zewei
    Lin, Zhiyuan
    Chen, Xiang
    Xiang, Zhuoyi
    Wang, Jiajun
    Bai, Qi
    Zhang, Weijuan
    Yang, Yuanfeng
    Guo, Jianming
    Xu, Jiejie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (05) : 731 - 741
  • [40] Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma
    Ying Xiong
    Li Liu
    Yu Xia
    Yangyang Qi
    Yifan Chen
    Lingli Chen
    Peipei Zhang
    Yunyi Kong
    Yang Qu
    Zewei Wang
    Zhiyuan Lin
    Xiang Chen
    Zhuoyi Xiang
    Jiajun Wang
    Qi Bai
    Weijuan Zhang
    Yuanfeng Yang
    Jianming Guo
    Jiejie Xu
    Cancer Immunology, Immunotherapy, 2019, 68 : 731 - 741
12345